Richmond, Dec. 05, 2023 (GLOBE NEWSWIRE) -- According to a research report "Antibody Discovery Market, By Source (Humanized Antibody, Human Antibody, Chimeric Antibody and Murine Antibody), Antibody Type (Monoclonal Antibodies (mAbs), Polyclonal Antibodies and Recombinant Antibodies), Method (Phage Display, Hybridoma, Transgenic Antibody Technology, Single B Cell Technology and Others), End-user (Pharmaceutical & Biotechnology industry, Research laboratory and Academic laboratory) and Region - Global Forecast to 2030.
Global Antibody Discovery Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 6.9 Billion |
| Market size value in 2030 | USD 13.7 Billion |
| CAGR (2023-2030) | 9.0% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Source, Antibody Type, Method, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3712
TOC Covers in Depth & Breath on Antibody Discovery Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
In recent years, the antibody discovery market has witnessed significant expansion, propelled by a growing need for precision therapeutics and the escalating incidence of chronic and infectious diseases. The process of antibody discovery entails the recognition and creation of antibodies designed to selectively bind to disease targets, presenting promising uses in diagnostics, therapeutics, and research. This market incorporates diverse technologies and platforms, including hybridoma technology, phage display, and transgenic animal models, facilitating the creation and enhancement of antibodies tailored for particular disease indications.
Major Vendors in the Global Antibody Discovery Market:
- Biocytogen
- Charles River Laboratories
- Creative Biolabs
- Danaher Corporation
- Eurofins Scientific
- Evotec
- Fairjourney Biologics S.A
- Genscript Technology Corporation
- Sartorius AG
- Twist Bioscience
Request for Discount @ https://www.marketdigits.com/request/discount/3712
Increasing Demand for Targeted Therapeutics
The antibody discovery market is witnessing a surge in demand for targeted therapeutics, marking a notable trend in recent times. This heightened demand is driven by the recognition of the unique advantages offered by targeted therapeutic approaches. As precision medicine gains prominence, there is an increasing emphasis on developing antibodies that can specifically bind to disease targets. This targeted therapeutic strategy not only enhances treatment efficacy but also minimizes adverse effects on healthy tissues, showcasing a promising paradigm shift in the field of antibody discovery. The market is dynamically responding to this shift, with researchers and pharmaceutical entities actively pursuing innovative solutions to cater to the rising need for precision in therapeutic interventions.
Market Dynamics
Drivers:
- Rising Prevalence of Chronic and Infectious Diseases
- Increasing Research and Development Investment
- Advancements in antibody engineering
Opportunities:
- Development of new antibody-based therapies
- Development of novel antibody discovery platforms
- Expansion into new therapeutic areas
Increased adoption of personalized medicine
The Antibody Discovery Market is witnessing an increased adoption of personalized medicine, reflecting a paradigm shift in healthcare strategies. The recognition of individual variations in genetic makeup, responses to treatments, and disease manifestations has fueled the integration of personalized medicine into antibody discovery. This approach tailors medical interventions to the unique characteristics of each patient, maximizing treatment efficacy and minimizing adverse effects. The Antibody Discovery Market's alignment with personalized medicine signifies a progressive move towards more precise and patient-centric therapeutic solutions, harnessing the potential of antibodies to cater to the specific needs and genetic profiles of individuals.
The market for Antibody Discovery is dominated by North America.
In 2022, the North American antibody discovery market is anticipated to dominate in the forecast period, propelled by an increase in cancer prevalence, a robust presence of the antibody discovery industry, and technological advancements in the R&D sector. For instance, in 2020, the American Cancer Society reported approximately 1.8 million new cancer cases and 606,520 cancer-related deaths in the U.S., underscoring the demand for therapeutic antibodies and stimulating market growth. The upsurge in funding facilitates the development of novel technologies, collaborative efforts spanning countries and organizations, and the exploration of existing antibody treatments, contributing to a deeper understanding of the immune system and the effective development of targeted antibodies. Moreover, augmented funding enables large-scale clinical trials essential for evaluating antibody efficacy, thereby enhancing the overall growth trajectory of the market.
On the other hand, the Asia-Pacific antibody discovery market is poised for expansion in the forecast period due to an increase in the incidence of cardiovascular diseases and other chronic health conditions. As reported by the Journal of Biomedical and Environmental Science in 2021, approximately 330 million individuals in China experienced cardiovascular diseases. The significance of antibody discovery becomes evident in the creation of innovative therapeutics for addressing cardiovascular ailments. Consequently, the rising prevalence of heart diseases amplifies the demand for antibody discovery, playing a pivotal role in propelling market growth.
The Phage Display Antibody Discovery Segment is Anticipated to Hold the Largest Market Share During the Forecast Period
Based on technology the antibody discovery market is segmented into Phage Display, Hybridoma, Transgenic Antibody Technology, Single B Cell Technology and Others. The dominance of the phage display segment in the antibody discovery market is anticipated to persist. Phage display facilitates the generation of diverse antibody libraries, encompassing fully human, humanized, or synthetic libraries, thereby increasing the likelihood of identifying antibodies with optimal therapeutic characteristics. This method finds widespread application in target discovery, enabling researchers to pinpoint antibodies effective against a broad spectrum of targets, including proteins, peptides, and small molecules. Its versatility renders it a favored option in drug discovery. Through phage display, researchers can screen for functional antibodies that not only bind to the target but also demonstrate specific biological activities, such as receptor blocking or pathogen neutralization. The technique allows the selection of high-affinity antibodies through successive rounds of panning and amplification, ensuring the isolation of antibodies with robust and specific binding to the target.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3712
Browse Similar Reports:
Novel Antibody Therapy Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Single-cell Omics Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Cell Lysis and Disruption Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
